HOME KITS FOR GENE TESTS

Psynome– tests for two mutations in the GRK3 gene that are associated with bipolar disorder. Patients who have either of these two mutations, are Caucasian, of Northern European ancestry and have a family history of bipolar disorder, are three times more likely to have bipolar disorder.
Psynome2 – tests for mutations in the Promoter L allele gene that predicts patient response to serotonin-based drugs, the most commonly prescribed drug therapies today. No other DNA test exists today to identify an individuals positive or negative response to SSRIs. The serotonin transporter gene is associated with response to SSRI antidepressants, as well as, several other traits including vulnerability to stress induced major depression. Patients with one of two genotype mutations that are Caucasian and suffering from depression, are twice as likely to benefit from treatment with an SSRI type of antidepressant.